Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

Today Beasley Allen filed two complaints in multidistrict litigation (MDL) on behalf of clients injured by gadolinium.

Gadolinium is linked to adverse health effects on patients with renal insufficiency or kidney failure, including Nephrogenic Systemic Fibrosis (NSF), which causes fibrosis of the skin and connective tissues and scarring of organs including lungs, heart, and liver and may lead to death.

Beasley Allen attorneys Andy D. Birchfield, Jr., and Benjamin L. Locklar filed the complaint in United States District Court, Northern District of Ohio Eastern Division under Judge Dan Aaron Polster on behalf of plaintiffs Caroll L. Jett, a resident of Fulton County, Illinois, and Malicia A. Moody, a resident of Wilcox County, Alabama.

This is a Multidistrict Litigation (MDL) against defendants Bayer Corporation; Bayer Healthcare LLC; Bayer Pharmaceuticals Corporation; Bayer Healthcare Pharmaceuticals, Inc.; Berlex Laboratories, Inc.; Berlex, Inc.; Bayer Schering Pharma AG; and Bayer AG.

The complaint alleges the defendants designed, manufactured and marketed the gadolinium-based contrast agent Magnevist, which is an injectable Paramagnetic contrast agent for magnetic resonance imaging (MRI), containing the metal gadolinium.

The lawsuit alleges the manufacturers of the gadolinium-containing products acted in a conscious, intentional, willful, wanton, reckless, fraudulent and inappropriate way with total disregard for the rights and safety of those persons who used their products, and as a result the plaintiffs suffered significant and lasting harm.

Official Complaints

Gadolinium Lawsuit – Carroll Jett v. Gadolinium
Gadolinium Lawsuit – Malicia Moody v. Gadolinium

This entry was posted on Tuesday, March 17th, 2009 at 3:35 pm and is filed under Gadolinium Lawsuits, News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.